CXCL10 and infection: To examine the potential antiviral protective effects of the detected mediators, especially CXCL10 [37], [38] and type I IFNs, 48 h post-infection supernatants from mock- or variously treated CBMCs were added to fresh, uninfected target KU812 cells.